Multiple Myeloma Clinical Trial

Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)

Summary

Multiple myeloma (MM) is a rare cancer caused by abnormal survival of plasma cells (blood cells). Most trial participants with MM relapse (cancer has come back) or become non- responsive to treatment and remission gets shorter after each line of treatment. This is a study to assess t(11;14) and BCL2 expression in adult participants with newly diagnosed and relapsed/refractory (R/R) MM.

Approximately 500 adult participants with newly confirmed or relapsed/refractory (R/R) multiple myeloma (MM) will be enrolled in around 15-20 countries.

Participants will receive standard of care while participating in this study. No drug will be administered as a part of this study.

Participants will attend regular visits during the course of the study at a hospital or clinic and will be asked to provide bone marrow and blood samples.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

- Confirmed newly diagnosed or relapsed/refractory (R/R) Multiple myeloma (MM) who have signed informed consent for the use of their biological material for research purposes.

Exclusion Criteria:

- Participants who do not have Bone Marrow (BM) and blood sample at time of diagnosis or at confirmation of relapse.

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

500

Study ID:

NCT04721002

Recruitment Status:

Recruiting

Sponsor:

AbbVie

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 40 Locations for this study

See Locations Near You

Tulane School of Medicine /ID# 223864
New Orleans Louisiana, 70112, United States
University of Texas Southwestern Medical Center /ID# 223865
Dallas Texas, 75390, United States
Hospital Italiano de Buenos Aires /ID# 224153
Ciudad Autonoma Buenos Aires Ciuadad Autonoma De Buenos Aires, 1199, Argentina
Alfred Health /ID# 224386
Melbourne Victoria, 3004, Australia
Hospital São Rafael /ID# 224307
Salvador Bahia, 41253, Brazil
Hospital de Clinicas de Porto Alegre /ID# 224274
Porto Alegre Rio Grande Do Sul, 90035, Brazil
Clinica Sao Germano /ID# 224239
São Paulo Sao Paulo, 04537, Brazil
Sociedade Beneficente Israelita Hospital Albert Einstein /ID# 224303
São Paulo Sao Paulo, 05652, Brazil
Instituto COI de Educacao e Pesquisa /ID# 224245
Rio de Janeiro , 22793, Brazil
Real e Benemérita Associação Portuguesa de Beneficência /ID# 224305
Sao Paulo , 01323, Brazil
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo /ID# 225749
Sao Paulo , 05403, Brazil
Cross Cancer Institute /ID# 224172
Edmonton Alberta, T6G 1, Canada
Klinicki bolnicki centar Zagreb /ID# 226969
Zagreb Grad Zagreb, 10000, Croatia
Fakultni nemocnice Hradec Kralove /ID# 224089
Hradec Kralove , 500 0, Czechia
Fakultni nemocnice Ostrava /ID# 224090
Ostrava , 708 5, Czechia
CHRU Lille - Hopital Claude Huriez /ID# 228919
Lille Hauts-de-France, 59037, France
CHU de Nantes, Hotel Dieu -HME /ID# 223702
Nantes Pays-de-la-Loire, 44000, France
AP-HP - Hopital Necker /ID# 228062
Paris , 75015, France
Praxis am Volkspark /ID# 224763
Berlin , 10715, Germany
Asklepios Klinik Altona /ID# 224761
Hamburg , 22763, Germany
Alexandra General Hospital /ID# 224828
Athens Attiki, 11528, Greece
Beaumont Hospital /ID# 225514
Beaumont Dublin, D09 X, Ireland
Hadassah Medical Center-Hebrew University /ID# 224884
Jerusalem Yerushalayim, 91120, Israel
Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona /ID# 224690
Ancona , 60126, Italy
ASST Grande Ospedale Metropolitano Niguarda /ID# 224608
Milano , 20162, Italy
Maastricht Universitair Medisch Centrum /ID# 224694
Maastricht , 6229 , Netherlands
Rikshospitalet OUS HF /ID# 227288
Oslo , 0450, Norway
Instytut Hematologii i Transfuzjologii /ID# 227039
Warszawa Mazowieckie, 02-77, Poland
Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Mar /ID# 227038
Poznan Wielkopolskie, 60-56, Poland
Institutul Clinic Fundeni /ID# 224574
Sector 2 Bucuresti, 02232, Romania
Princess Noorah Oncology Center /ID# 224968
Jeddah , 22384, Saudi Arabia
Univ Medical Ctr Ljubljana /ID# 225408
Ljubljana , 1000, Slovenia
Hospital Universitario Germans Trias i Pujol /ID# 229281
Badalona Barcelona, 08916, Spain
Hospital Clinic de Barcelona /ID# 224804
Barcelona , 08036, Spain
Hospital de Leon /ID# 229191
Leon , 24071, Spain
Hospital Universitario Fundacion Jimenez Diaz /ID# 229524
Madrid , 28040, Spain
Hospital Universitario 12 de Octubre /ID# 225617
Madrid , 28041, Spain
Hospital Universitario de Salamanca /ID# 224803
Salamanca , 37711, Spain
Taichung Veterans General Hospital /ID# 227084
Taichung , 40705, Taiwan
Bagcilar Medipol Mega Universite Hastanesi /ID# 225515
Istanbul , 34214, Turkey

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

500

Study ID:

NCT04721002

Recruitment Status:

Recruiting

Sponsor:


AbbVie

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.